Fungal Keratitis

Fungal keratitis, also known as keratomycosis, is a serious fungal infection of the cornea that poses a significant threat to equine vision. This condition represents one of the most challenging ocular infections to treat in horses, often requiring prolonged, intensive medical therapy and frequently resulting in some degree of permanent corneal damage. The fungi responsible for keratomycosis are typically opportunistic organisms found commonly in the environment, particularly in soil, plant material, and organic debris, making horses' exposure to these pathogens essentially ubiquitous.

The prevalence of fungal keratitis varies geographically, with significantly higher incidence in warm, humid climates where environmental conditions favor fungal growth. Regions with hot summers and mild winters, particularly in the southeastern United States and similar climates worldwide, see disproportionately more cases. Horses of all breeds, ages, and uses may be affected, though those with corneal injuries that provide a portal of entry for fungal organisms are at particular risk. Horses kept on pasture or in environments with abundant plant material and organic debris face greater exposure to potential pathogens.

The impact of fungal keratitis on equine health is substantial, as this infection threatens not only the vision in the affected eye but potentially the eye itself. Fungal infections of the cornea tend to be more invasive and destructive than bacterial corneal infections, with a propensity to penetrate deep into the corneal stroma and potentially the anterior chamber. The inflammatory response to fungal infection is often severe, leading to significant pain and frequently accompanying uveitis. Without appropriate treatment, fungal keratitis can progress to corneal perforation and loss of the eye. Even with treatment, scarring and visual impairment are common sequelae.

Fungal keratitis is treatable but demands early recognition, accurate diagnosis, and aggressive, prolonged antifungal therapy. Treatment typically extends for weeks to months, requiring significant commitment from owners for intensive medication schedules. Despite appropriate treatment, the prognosis for complete visual recovery is guarded, with many horses retaining some degree of corneal opacity. Early detection before deep corneal invasion occurs offers the best chance for favorable outcomes. Any horse with a corneal ulcer that fails to respond to standard antibiotic therapy should be evaluated for fungal involvement.

The primary causes of fungal keratitis are opportunistic fungal organisms that gain access to corneal tissue, usually through a pre-existing break in the corneal epithelium. The most commonly identified fungal agents in equine keratomycosis include Aspergillus species, Fusarium species, and various other filamentous fungi including Curvularia and Alternaria. Yeast organisms such as Candida species are less commonly implicated in horses compared to filamentous fungi. These organisms are environmental saprophytes found in soil, decomposing plant matter, and agricultural materials, making exposure essentially unavoidable for horses.

While fungal keratitis itself is not genetically determined, certain conformational or ocular characteristics may predispose individual horses to corneal injury that provides a portal of entry for fungal organisms. Horses with prominent eyes or shallow orbits may be more susceptible to corneal trauma. Those with incomplete eyelid closure or exposure problems face increased risk of corneal damage. Horses with pre-existing ocular surface disease, tear film abnormalities, or chronic irritation may have compromised corneal defenses. These predisposing factors are not strictly hereditary but may show familial patterns.

Environmental and management factors significantly influence the risk of fungal keratitis. Warm, humid climates provide optimal conditions for environmental fungal growth, correlating with increased incidence. Exposure to plant material during grazing, particularly in tall or rough vegetation, increases risk of corneal microtrauma. Dusty environments may introduce fungal spores and cause corneal irritation simultaneously. Previous corneal injury or surgery provides a portal for fungal entry. Inappropriate use of topical corticosteroids on corneal ulcers is a major predisposing factor, as corticosteroids suppress immune defenses while doing nothing to control fungal organisms and may even promote their growth.

Risk factors for developing fungal keratitis include any condition causing corneal epithelial disruption. Corneal foreign bodies, even when removed, create wounds susceptible to infection. Corneal trauma from any source, including blunt injury, scratches, or chemical irritation, provides entry points. Prior corneal ulceration, particularly if treated with topical corticosteroids, significantly increases risk. Concurrent systemic illness or immunosuppression compromises the ability to control opportunistic infections. Horses in heavy work may have increased corneal exposure to debris and environmental pathogens.

The pathophysiology of fungal keratitis involves fungal colonization and invasion of corneal tissue following epithelial disruption. Unlike bacteria, fungi can actively penetrate through intact corneal stroma using enzymatic processes. Filamentous fungi grow as branching hyphae that extend through corneal tissue, often spreading along tissue planes. The host inflammatory response to fungal elements causes additional tissue damage. Fungal antigens may trigger intense immune-mediated inflammation, contributing to the severity of the clinical presentation. Secondary bacterial infection frequently complicates fungal keratitis. The inflammatory process often extends to involve the anterior uveal tract, causing concurrent uveitis. The combination of direct fungal invasion, enzymatic degradation, and inflammatory tissue destruction can lead to rapid corneal thinning and potential perforation.

Early warning signs of fungal keratitis may be difficult to distinguish from bacterial corneal ulceration initially, though certain features should raise suspicion for fungal involvement. A corneal ulcer that fails to improve or worsens despite appropriate antibiotic therapy is a significant warning sign. Corneal lesions with irregular, feathery, or indistinct margins may suggest fungal infection compared to the typically sharper borders of bacterial ulcers. The presence of satellite lesions surrounding a primary lesion is characteristic of fungal infections. White or yellow-gray stromal infiltrates with a raised or fluffy texture may indicate fungal presence. Any corneal ulcer in a horse receiving topical corticosteroids should be immediately suspected for fungal involvement.

Common symptoms of established fungal keratitis include visible corneal opacity ranging from white to yellow-gray coloration, often with a distinctive dry or matte texture described as having a cotton-like or paint-like appearance. The cornea may show raised plaque-like lesions where fungal elements have accumulated. Significant surrounding corneal edema, appearing as a bluish haze, typically accompanies the active infection. Intense ocular pain manifests as blepharospasm with the eyelids held tightly closed, along with excessive tearing and discomfort. Deep corneal vascularization may be present if the infection has been ongoing, with blood vessels growing into the cornea from the limbus.

Behavioral changes in horses with fungal keratitis reflect the significant pain associated with this condition. Affected horses are typically extremely head shy on the affected side, resisting any approach to the eye. Depression and decreased appetite are common, reflecting systemic effects of severe pain. The horse may seek darkened areas due to pronounced photophobia. Reluctance to work or move about normally may be observed. Some horses become agitated or demonstrate pain behaviors including pawing or rubbing the affected side. The degree of behavioral change often exceeds that seen with uncomplicated bacterial ulcers.

Physical signs visible on examination extend beyond the corneal lesion itself. The conjunctiva is typically severely inflamed, appearing deep red with prominent blood vessel injection. The third eyelid may be prolapsed across the eye in response to pain. Periocular swelling may be present. Hypopyon, an accumulation of white inflammatory cells visible in the anterior chamber, frequently accompanies fungal keratitis and indicates significant intraocular inflammation. The pupil may appear constricted due to concurrent uveitis. In advanced cases, corneal thinning may be visible, with the bulging appearance of a descemetocele signaling imminent perforation.

Symptom progression in fungal keratitis can be insidious or rapid, depending on the infecting organism and host factors. Some cases develop gradually over days to weeks, with slowly expanding corneal infiltrates. Others progress rapidly with dramatic worsening over just a few days. Without appropriate treatment, the infection extends deeper into the corneal stroma and may penetrate into the anterior chamber. Corneal necrosis and melting may develop, leading to progressive thinning. Perforation of the cornea represents a critical stage that threatens loss of the eye.

Emergency symptoms requiring immediate veterinary intervention include any signs of corneal thinning or bulging that suggest imminent perforation. Sudden change in the shape of the pupil may indicate lens prolapse through a perforated cornea. Collapse or loss of volume of the globe suggests perforation has occurred. Sudden decrease in pain in an eye that was previously severely painful may paradoxically indicate perforation, as the cornea has lost sensation. Rapidly progressive deterioration of the corneal lesion despite treatment indicates the current therapy is inadequate and aggressive intervention is needed.

Physical examination of a horse with suspected fungal keratitis requires thorough ophthalmic evaluation, often performed after sedation and application of topical anesthetic to allow adequate assessment of a painful eye. The veterinarian examines the corneal lesion characteristics, noting the appearance, depth, and extent of the ulcer or infiltrate. Features suggesting fungal involvement include feathery or indistinct margins, satellite lesions, elevated plaques, and the distinctive dry, gray-white appearance of fungal infiltrates. The anterior chamber is evaluated for hypopyon and other signs of uveitis. Both eyes are examined, as occasionally bilateral involvement occurs.

Diagnostic tests essential for confirming fungal keratitis include corneal cytology and culture. Samples are obtained by scraping the margins and base of the corneal lesion using a sterile spatula or cytobrush. Material is applied to glass slides for staining and microscopic examination. Cytology may reveal fungal hyphae or yeast forms, providing rapid presumptive diagnosis while cultures are pending. Samples are also submitted for fungal culture on appropriate media such as Sabouraud dextrose agar, which can identify the specific fungal organism and may guide antifungal drug selection. Because fungi grow slowly in culture, results may take days to weeks. Bacterial culture is performed simultaneously to identify concurrent bacterial infection.

Advanced diagnostics may be employed in complex or refractory cases. Corneal biopsy provides tissue for histopathologic examination, which may reveal fungal elements not detected on cytology. Special stains including periodic acid-Schiff (PAS) and Gomori methenamine silver (GMS) highlight fungal structures in tissue sections. In some cases, molecular diagnostic techniques such as polymerase chain reaction (PCR) can identify fungal DNA in corneal samples, offering faster results than traditional culture. Confocal microscopy, available at specialty centers, allows in vivo visualization of fungal hyphae within corneal tissue. Ocular ultrasound evaluates the anterior chamber and posterior segment for complications.

Differential diagnosis for fungal keratitis includes other causes of corneal ulceration and infiltration. Bacterial keratitis may present similarly but typically responds to antibiotic therapy. Sterile or immune-mediated keratitis may cause corneal infiltration without infection. Corneal foreign bodies can cause localized infiltration around the foreign material. Eosinophilic keratitis causes raised, proliferative corneal lesions with a different appearance. Corneal stromal abscess represents walled-off infection that may be bacterial or fungal. The history of corticosteroid use, characteristic lesion morphology, and laboratory confirmation help distinguish fungal keratitis from these alternatives.

Emergency treatment of fungal keratitis involves immediate cessation of any topical corticosteroid therapy, which exacerbates fungal infection. The horse is started on intensive topical antifungal medication while awaiting diagnostic test results, as delayed treatment allows progression of this destructive infection. Pain management with systemic non-steroidal anti-inflammatory drugs improves patient comfort and allows for better examination and medication. Atropine is applied topically to dilate the pupil, which reduces pain from ciliary muscle spasm and helps prevent adhesion of the inflamed iris to the lens. The frequency of medication may initially be hourly or even more frequent for severe cases.

Medical management of fungal keratitis is intensive and prolonged, typically extending for weeks to months. Topical antifungal agents are the mainstay of treatment, with options including natamycin, which has excellent activity against Fusarium and many other filamentous fungi; voriconazole or miconazole for broad-spectrum coverage; and itraconazole or fluconazole preparations. Multiple antifungal agents may be used in combination. Initial frequency may be every one to two hours around the clock, gradually reduced as the infection comes under control. Subpalpebral lavage systems are frequently placed to facilitate frequent medication delivery. Systemic antifungal agents including oral voriconazole or fluconazole may be added for deep or severe infections.

Surgical options become necessary when medical management alone is insufficient or when complications develop. Debridement of necrotic tissue and fungal plaques may enhance medication penetration and reduce fungal load. Keratectomy involves surgical removal of infected corneal tissue and is indicated for localized infections that are not responding to medical therapy. Corneal transplantation may be considered for deep infections threatening perforation or for perforation that has occurred. Conjunctival grafts provide blood supply and structural support to severely compromised corneas. In cases where the eye cannot be saved or quality of life is severely affected, enucleation may be the most humane option.

Supportive care is essential throughout treatment. Topical atropine maintains pupil dilation and reduces uveitis-associated pain. Systemic anti-inflammatory medications including flunixin meglumine provide analgesia and reduce inflammation. Serum or plasma applied topically provides anticollagenase activity to reduce corneal melting. Broad-spectrum topical antibiotics prevent or treat concurrent bacterial infection. The horse should be kept in a clean, dust-free environment. Fly masks protect the eye from insects and debris. Nutritional support ensures the horse maintains condition during the prolonged treatment period.

Rehabilitation and return to work following fungal keratitis depends on the extent of residual corneal damage. Horses require complete resolution of active infection before any consideration of return to activity. Corneal scarring may persist indefinitely, with implications for vision depending on scar location and density. Horses with central corneal scars affecting the visual axis may have impaired vision in that eye. Gradual reintroduction to work, beginning with light activity in controlled environments, allows assessment of the horse's adaptation to any visual changes. Some horses return to full athletic function despite corneal scarring.

Treatment decision factors include the severity and depth of infection, the specific fungal organism if identified, response to initial therapy, owner ability to provide intensive medication schedules, cost considerations for prolonged treatment, the horse's intended use, and quality of life. Horses with shallow infections detected early have the best prognosis. Deep infections threatening perforation may require surgical intervention. The intensity and duration of treatment demand significant owner commitment. Referral to a veterinary ophthalmologist is advisable for severe cases or those not responding to initial therapy.

Recovery timeline for fungal keratitis is measured in weeks to months rather than days. Initial response to treatment may not be apparent for several days, and premature reduction in treatment intensity risks recurrence. Active treatment typically continues for a minimum of two to four weeks after apparent clinical resolution, as fungal organisms can persist deep within corneal tissue. Complete healing of the corneal lesion with re-epithelialization may take four to eight weeks or longer. Corneal scarring that results from the infection continues to remodel for months, with gradual improvement in appearance over six to twelve months in many cases.

Post-treatment care and monitoring remain important long after the acute infection has resolved. Medications are tapered gradually rather than stopped abruptly, with ongoing monitoring for any signs of recurrence. Regular veterinary examinations, initially weekly and then at increasing intervals, assess healing and detect any complications. The treated eye remains at risk for recurrence and should be monitored for any return of symptoms. Any new signs of ocular pain, discharge, or cloudiness require immediate veterinary evaluation. Long-term topical lubricants may benefit eyes with corneal scarring or altered tear film dynamics.

Prognosis factors influencing recovery include the depth and extent of infection at presentation, the specific fungal organism involved, timeliness of diagnosis and initiation of appropriate therapy, development of complications including corneal perforation, and the horse's response to treatment. Superficial infections detected early and treated aggressively have the best outcomes. Deep stromal infections that threaten or have caused perforation carry guarded to poor prognosis for vision, though the eye may often be saved with aggressive treatment. Fusarium infections may be particularly challenging to treat due to some degree of antifungal resistance.

Long-term outlook for horses that have recovered from fungal keratitis varies based on residual corneal damage. Many horses retain some degree of corneal scarring, appearing as white or gray opacity in the area of previous infection. The impact on vision depends on scar location, with central scars affecting the visual axis having greater functional significance than peripheral scars. Horses generally adapt well to unilateral visual impairment and can continue in many activities. The treated eye remains at risk for recurrence and should be monitored indefinitely. Annual or semi-annual ophthalmic examinations are advisable. Despite the severity of this condition, many horses make functional recoveries and return to useful lives.

Prevention of fungal keratitis centers on minimizing corneal injury that provides a portal of entry for fungal organisms and on appropriate management of any corneal injuries that do occur. Management practices that reduce environmental hazards and corneal injury risk form the foundation of prevention. Maintaining facilities free of sharp edges, protruding nails, and other ocular hazards reduces trauma risk. Fly masks with mesh eye coverage provide physical protection from insects and environmental debris during turnout. Horses should be observed regularly for any signs of ocular injury or irritation, allowing early intervention before complications develop.

Nutritional factors supporting overall immune competence contribute to the body's ability to resist infection, though no specific nutritional interventions directly prevent fungal keratitis. Ensuring balanced nutrition with adequate vitamins and minerals supports robust immune function. Vitamin A is particularly important for maintaining healthy epithelial tissues including the cornea and conjunctiva. Omega-3 fatty acids may support healthy tear film and ocular surface function. Maintaining appropriate body condition supports overall health and disease resistance.

Exercise and conditioning considerations for prevention relate primarily to managing eye protection during activities that pose increased risk of corneal exposure or trauma. Horses working in dusty arenas or on trails with overhanging vegetation may benefit from fly masks or protective equipment. Rinsing eyes with sterile saline after exposure to dusty or debris-laden environments may help remove potentially harmful material. Ensuring horses cool down properly after exercise reduces excessive sweating around the eyes.

Environmental factors are significant in fungal keratitis prevention given the ubiquitous nature of causative organisms in the horse's surroundings. Reducing exposure to decaying organic matter, particularly in warm and humid conditions, may lower fungal load in the immediate environment. Proper hay storage minimizes mold growth. Manure management and general cleanliness reduce environmental pathogen levels. Good ventilation in barns prevents humidity buildup. Geographic considerations acknowledge that horses in warm, humid climates face inherently greater risk.

Critically important for prevention is appropriate management of any corneal injury or ulceration. Topical corticosteroids should never be applied to a corneal ulcer unless fungal infection has been definitively ruled out and the eye is being closely monitored by a veterinarian. Any corneal ulcer that does not respond to appropriate antibiotic therapy within a few days should be reassessed, with fungal culture and cytology performed. Early detection and treatment of small corneal injuries before fungal colonization occurs is far preferable to treating established fungal keratitis. Regular veterinary attention to ocular injuries, rather than waiting to see if they improve spontaneously, reduces the risk of progression to serious infection.

Daily management adjustments for horses undergoing treatment for fungal keratitis focus on maintaining the intensive medication schedule, protecting the affected eye, and supporting overall health during the prolonged treatment period. Medication administration, often required every one to four hours initially, demands significant time commitment and may require help from multiple caregivers. Subpalpebral lavage systems, when placed, require proper maintenance and monitoring for patency and comfort. The eye should be observed before each treatment for any changes that might indicate improvement or deterioration. The horse should be kept in a clean, dust-free environment to minimize additional corneal exposure to debris and potential pathogens.

Housing and turnout considerations during treatment for fungal keratitis prioritize protection and ease of medication administration. Stall rest is typically required, at least initially, to facilitate frequent treatments and reduce environmental exposure. The stall should be clean, well-bedded, and free of dust. Low-dust bedding options such as paper products or well-screened shavings are preferable. Ventilation should be adequate without creating drafts. As the infection comes under control and medication frequency decreases, limited turnout in a small, clean paddock may be gradually introduced under veterinary guidance. Fly masks provide protection whenever the horse is not being directly treated.

Exercise modifications during fungal keratitis treatment are substantial, with most horses requiring rest during the active treatment phase. The pain and visual impairment associated with the infection, combined with the need for frequent medication, preclude normal activity. As healing progresses and treatment intensity decreases, hand walking in controlled environments may begin. Return to under-saddle work awaits significant healing and veterinary clearance. The timeline for return to full activity extends well beyond resolution of active infection, typically several months, to allow for corneal stability.

Monitoring and ongoing care during treatment involve close observation of the clinical appearance of the eye, the horse's comfort level, and response to therapy. Any sudden changes, particularly worsening, should prompt immediate veterinary consultation. The appearance of the corneal lesion, the degree of corneal edema, the presence of hypopyon, and the horse's pain level are all assessed regularly. Medication efficacy and any adverse reactions are noted. Follow-up veterinary examinations at intervals determined by the treating veterinarian guide treatment adjustments. After resolution, monitoring for recurrence continues indefinitely.

Quality of life considerations during fungal keratitis treatment acknowledge that this is a challenging condition for both horse and owner. The prolonged intensive treatment is demanding, and some horses become resentful of repeated medication. Creative approaches to minimize stress during treatment may be needed. The prognosis for complete visual recovery is guarded, and owners should be prepared for the possibility of residual scarring or vision loss. However, many horses do recover meaningful vision and continue in productive lives. Open communication with the treating veterinarian about expectations, progress, and decision-making supports optimal care throughout the prolonged treatment process.

Fungal keratitis does not demonstrate breed predilection in the traditional sense, as susceptibility relates primarily to environmental exposure and predisposing factors rather than genetics. All horse breeds are susceptible when exposure to causative fungi and predisposing conditions align. However, certain breed characteristics and typical uses may influence risk profiles. Horses with prominent eyes and more exposed corneal surfaces may theoretically face greater risk of the corneal trauma that provides entry for fungi. Draft breeds with proportionally smaller eyes relative to head size may have somewhat more protected globes. These conformational considerations have not been definitively studied in relation to fungal keratitis incidence.

Use and discipline considerations affect fungal keratitis risk primarily through environmental exposure patterns. Horses kept on pasture, particularly in warm humid climates with abundant vegetation, face greater exposure to environmental fungi than those kept primarily in stalls. Horses used in disciplines requiring work in natural settings with vegetation, such as trail riding, endurance, or ranch work, may have increased exposure. Sport horses working in artificial footing may have different, though not necessarily lower, risk profiles. Racehorses and other horses kept in intensive management systems may have less environmental exposure but face other risk factors. Geographic location significantly influences risk regardless of breed or discipline.

Genetic testing is not applicable to fungal keratitis risk, as this is an acquired infectious condition rather than a genetic disease. Breeding recommendations relate more to general ocular health considerations than to specific fungal keratitis concerns. Selecting for normal eyelid conformation and appropriate eye position within the orbit supports overall ocular health. Avoiding breeding horses with chronic ocular surface disease that might predispose to corneal problems is prudent. Beyond these general considerations, there are no specific genetic factors to consider in relation to fungal keratitis susceptibility, and all horses should be considered potentially at risk when appropriate environmental and predisposing factors are present.

Commonly co-occurring conditions with fungal keratitis include anterior uveitis, which develops in the vast majority of cases as inflammation extends from the cornea to involve the iris and ciliary body. The uveitis component of the disease requires concurrent treatment and significantly affects prognosis for vision. Bacterial keratitis may be present simultaneously with fungal infection, requiring treatment with both antibiotics and antifungals. Corneal stromal abscess may develop as the infection becomes walled off within the cornea. Secondary glaucoma may develop from inflammatory debris blocking aqueous outflow. Corneal perforation represents a serious complication requiring emergency intervention.

Conditions with similar symptoms that must be distinguished from fungal keratitis include bacterial keratitis, which often presents with more distinct lesion margins and responds to antibiotic therapy. Sterile or immune-mediated keratitis may cause corneal infiltration without infection and requires different treatment. Corneal foreign bodies cause localized reactions that resolve with foreign body removal. Eosinophilic keratitis creates raised, vascularized lesions with distinctive appearance. Herpesvirus keratitis in horses, though less common than in cats, may cause dendritic or geographic corneal lesions. Laboratory testing including cytology and culture is essential to differentiate these conditions, as treatment differs significantly.

Potential complications of fungal keratitis include permanent corneal scarring resulting in vision impairment, the degree of which depends on scar location relative to the visual axis. Corneal perforation may occur if the infection erodes through the full thickness of the cornea, potentially leading to loss of the eye. Chronic uveitis with its sequelae including cataracts, lens luxation, and phthisis bulbi may develop. Secondary glaucoma from inflammatory damage to aqueous outflow pathways threatens additional vision loss. Recurrence of infection is possible, particularly if treatment is discontinued prematurely. In severe cases, enucleation may be necessary despite treatment efforts. The potential for these serious complications underscores the importance of early aggressive treatment and vigilant monitoring.